LEX-WK-36PVFKZCcrawled 2022-08-24 12:44Z
FDA’s Marketing Denial Order Issued to Bidi Vapor’s Non-Tobacco Flavored ENDS Products are Set Aside and Remanded by the 11th Circuit Court of Appeals for being Arbitrary and Capricious
Azim Chowdhury · Eric P. Gotting · The Continuum of Risk · Published August 24, 2022
Work details
- author
- Azim Chowdhury · Eric P. Gotting
- firm or organization
- Keller Heckman
- publication
- The Continuum of Risk
- practice area
- Administrative and Regulatory · Health Care and Life Sciences
- published
- 2022-08-24
Citation
Azim Chowdhury, Eric P. Gotting, FDA’s Marketing Denial Order Issued to Bidi Vapor’s Non-Tobacco Flavored ENDS Products are Set Aside and Remanded by the 11th Circuit Court of Appeals for being Arbitrary and Capricious, The Continuum of Risk (August 24, 2022) [The Library at LexBlog, LEX-WK-36PVFKZC, lexpid.org/36PVFKZC]